Arch Biopartners (ARCH) Stock Price, News & Analysis

Company Overview

Key Stats

• Today's Range: $134.83 to $134.83
• 50-Day Range: N/A
• 52-Week Range: $116.44 to $180.65
• Volume: N/A
• Average Volume: 358,966 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

ARCH Stock Analysis - Frequently Asked Questions

How have ARCH shares performed this year?

Arch Biopartners' stock was trading at $134.83 at the beginning of 2025. Since then, ARCH stock has increased by 0.0% and is now trading at $134.83.
View the best growth stocks for 2025 here.

How do I buy shares of Arch Biopartners?

Shares of ARCH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Arch Biopartners own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Arch Biopartners investors own include NVIDIA (NVDA), Meta Platforms (META), Advanced Micro Devices (AMD), Broadcom (AVGO), Adobe (ADBE), CrowdStrike (CRWD) and Palo Alto Networks (PANW).

Industry, Sector and Symbol

• Stock Exchange: NYSE
• Sector: N/A
• Industry: N/A
• Sub-Industry: N/A
• Current Symbol: NYSE:ARCH
• CIK: 1037676
• Web: N/A
• Phone: (647) 428-7031
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: N/A
• Beta: N/A